Korea’s aesthetic medicine enjoys golden era with surge in foreign spending

As beauty-conscious tourists continue to flock to Seoul’s clinics, South Korea’s aesthetic medicine sector may be entering a golden era,...

Celltrion unveils cancer medicine to expand new drug pipelines

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...

Naver’s Webtoon hints at ad business expansion in 2025

Webtoon Entertainment Inc., the Nasdaq-listed storytelling platform operator under South Korea’s internet giant Naver Corp., is set to expand ...

Chong Kun Dang to build new plant for foray into biologics market

Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with th...

Samyang enters Australia, New Zealand with allulose approval

South Korean chemical and food ingredient manufacturer Samyang Corp. said on Wednesday that it has become the first allulose producer to secure appr...

SK Group’s 3rd-generation daughter comes to the fore

Chey Yoon-chung, the eldest daughter of SK Group Chairman Chey Tae-won, unexpectedly made her debut during an SK Biopharmaceuticals Co. video confer...

Yuhan’s lung cancer drug clears FDA hurdle for global debut

A new lung cancer treatment developed by South Korea’s Yuhan Corp. has secured approval from the US Food and Drug Administration (FDA) as a co...

Naver's webtoon unit to raise $315 mn via Nasdaq IPO

Webtoon Entertainment Inc., South Korean tech giant Naver Corp.'s online comics platform, said on Thursday that it will raise $315 million by issuin...

Netmarble leverages existing IPs, M&As to keep growth

Expectations are growing high that Netmarble Corp., South Korea’s second-largest game developer and publisher, will extend its growth streak t...

Investors dump Korean biotech HLB stocks on FDA rejection

HLB Co. and its affiliate stocks tumbled on Friday on news that the South Korean biotech group’s highly anticipated new cancer treatment Rivoc...

Korea’s booming medical tourism: Skin care, plastic surgery in demand

The number of foreign patients visiting South Korea for medical tourism hit a record high last year, driven by those who traveled to Korea for skin ...

Daewoong gets stem cell facility license in Indonesia

South Korea's Daewoong Pharmaceutical announced on Tuesday that its subsidiary Daewoong Biologics Indonesia has obtained a stem cell Lab Operational...

Celltrion to sell portfolio of Takeda drugs to CBC Group

South Korea’s Celltrion Inc. will divest of a portfolio of Takeda Pharmaceutical's prescription medicines sold in Asia to CBC Group, a Singapo...

Samsung Bioepis gets FDA OK for its interchangeable biosimilar

Byooviz, a biosimilar of the macular degeneration treatment Lucentis and made by South Korea’s Samsung Bioepis, has received official design...

Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved

South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...

Daewoong Pharma's GER drug gets product OK from Mexico

South Korea’s Daewoong Pharmaceutical on Wednesday said its gastroesophageal reflux (GER) disease drug Fexuclue (active ingredient fexuprazan ...

Gluten-free Korean snack, pea soy sauce lure European gourmets

COLOGNE, Germany – The traditional Korean snack yakgwa and a soy-like sauce made with peas were named innovative foods of the year at the worl...

Genome & Co.’s bile duct cancer drug candidate enters Phase 2 trials

Genome & Company, a South Korean developer of microbiome-based drugs, on Tuesday said its GEN-001, a leading immunotherapy drug candidate for bi...

Moderna signs mRNA access deals with S.Korea's universities

The US biotech and pharmaceutical company Moderna on Friday announced signings of contracts with the academic-industry cooperation foundations of Ko...

S.Korea’s web novel sector hits $750 mn in value: Study

South Korea's rising web novel industry, which has seen popular works like "Reborn Rich" and "The Red Sleeve" made into TV series, has exceeded 1 tr...

Celltrion’s Vegzelma listed on prescription of 10 private US insurers

South Korea’s Celltrion Healthcare Co. announced on Wednesday that it has signed contracts with 10 insurance providers in the US to boost the ...

SK Bioscience buys 6.5 million Novavax shares for $83.4 million

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Wednesday it has signed a deal to buy 6.5 million shares in US vacc...

CJ Logistics to enter global pharmaceutical transportation market

South Korea’s CJ Logistics on Wednesday said it obtained the certification CEIV Pharma, or the Center of Excellence for Independent Validators...

SK Biopharmaceuticals gets OK to sell epilepsy drug in Canada

South Korea's SK Biopharmaceuticals has received approval in Canada to sell its new epilepsy drug Cenobamate under the product name Xcopri. Having e...

Kakao Entertainment launches AI brand Helix

South Korea's Kakao Entertainment on Thursday launched the artificial intelligence (AI) brand Helix, with its first service Helix Push recommending ...

Blackstone seeks medicine distributor sale for 1st Korea exit

Blackstone Inc. has embarked on the process of selling South Korea’s largest medicine wholesaler Geo-Young Corp., a deal estimated at up to $1...

Samsung Biologics wins $897 mn in two deals with Pfizer

Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO) in terms of production capacity, said on Tuesday it has w...

Celltrion applies for approval in US for eye treatment biosimilar

South Korean biopharmaceutical company Celltrion Inc. on Friday said it applied for approval from the US Food and Drug Administration (FDA) for CT-P...

S.Korea's Osteonic starts sports medicine exports to Japan

South Korea's surgical and medical instruments maker Osteonic Co. on Thursday announced the start of exports of its Kinex sports medicine products t...

S.Korea's Kainos Medicine exports AIDS treatment technology to China

South Korean new drug developer Kainos Medicine Inc. announced on Friday that it had signed a technology transfer agreement with Chinese pharmaceuti...